MAP2K2 and cancer: Of note, an altered kinase signaling network involving EGFR, PDGFR, PAK1, PTK2 (FAK), PRKCD, and MAP2K2 appear to regulate the aberrant changes in the cancer cells and the TME accompanying recurrence.